Based   20 industry collaborations,    realistic  expect,   minimum, CoRE  reduce preclinical attrition 5%, preclinical costs 20%  lead optimization costs 40%. When   parameters  adjusted    assessment  pharmaceutical R&D productivity (Paul  al. 2010 )  capture  effects   CoRE,  translated  capitalized costs savings  $238   --pocket cost reductions  $88 .  Additionally, CoRE   yield  reductions  time    instrumental  gaining  mover IP advantage,    targets.
